Defining the Basis of Fibromuscular Dysplasia (FMD) (DEFINE)
Defining the Basis of Fibromuscular Dysplasia: The Define-FMD Study
Sponsor: Icahn School of Medicine at Mount Sinai
This observational or N/A phase trial investigates Cervical Artery Dissection and Fibromuscular Dysplasia and is currently actively recruiting participants. Icahn School of Medicine at Mount Sinai leads this study, which shows 18 recorded versions since 2013 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
18 versions recorded-
Oct 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Oct 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Oct 2023 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Recruiting
-
Jun 2019 — Jan 2020 [monthly]
Recruiting
-
Jul 2018 — Jun 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .